Sr. Director, TAIP TA Lead – Trial Analytics, Insights, and Planning (TAIP) at Bristol-Myers Squibb

Princeton, New Jersey, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceutical, BiotechnologyIndustries

Requirements

Senior leadership experience in a similar role, reporting to head of unit in clinical development or analytics organization
Strong foundation in clinical trial science and applied analytics
Ability to translate insights into strategies impacting trial timelines and delivery outcomes
Experience in one or more of: Oncology, Neuroscience, Cell Therapy, Hematology, Immunology, or Cardiovascular
Experience managing direct reports across multiple levels and geographies, including performance management, career development, and day-to-day support
Skills in global collaboration, coaching, strategic advising, and influencing TA medical, clinical, and operational leadership

Responsibilities

Manage a team of direct reports, including performance management, career development, and day-to-day support
Lead the analytics strategy and execution across a global portfolio of trials within assigned therapeutic area (TA)
Guide, support, and review work across study-level analytics leads, acting as both coach and strategic sounding board
Track delivery progress across trials, escalating risks and ensuring alignment with trial milestones and enterprise priorities
Serve as a strategic advisor to TA leadership, shaping trial strategy, feasibility, and portfolio-level planning through data-driven insights
Ensure cross-trial consistency and innovation in forecasting, feasibility modelling, performance dashboards, and protocol analytics
Promote global collaboration, coordinating across teams to ensure effective, scalable delivery
Lead discussions on cost implications of country mix and study design decisions at the portfolio level
Promote study optimization analytics across trials, including evaluation of patient and site burden and competitive landscape data
Coordinate field-based insights into TA-wide feasibility and site prioritization approaches
Champion use of platforms, tools, and data infrastructure

Skills

Trial Analytics

Feasibility Modeling

Strategic Trial Planning

Data-Driven Insights

Clinical Development

Analytics Strategy

Portfolio Management

Team Leadership

Performance Management

Global Analytics

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free